Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LASSARAB Vaccine in Healthy Adults
NCT06546709Phase 1Completed
- Start
- Jan 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of amphotericin B + Lassar's paste in Lassa fever and rabies (4 cohorts). Primary endpoints: Solicited local and systemic events, Unsolicited events and 6 more. Started Jan 2025; status: completed.
02
Drugs
amphotericin B + Lassar's paste
03
Conditions
Lassa feverrabies
Beyond the preview
Go deeper on NCT06546709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06546709.